NASDAQ:KMDA

Kamada Stock News

Healthcare > Drug Manufacturers - Specialty & Generic

Buy KMDA

*Your capital is at risk

$7.39

-0.120 (-1.60%)

At Close: Jun 03, 2026

Kamada Wins a 12 Year Supply Contract Which is Expected to Add $8-$10M of Annual Revenue

12:00am, Monday, 09'th Dec 2019

Kamada Enters into Partnership with Alvotech for Commercialization of Six Biosimilar Products in Israel

12:00pm, Monday, 02'nd Dec 2019

Kamada Ltd. (Nasdaq: KMDA; TASE: KMDA.TA), today announced that it has entered into an agreement with Alvotech, a global biopharmaceutical company, to commercialize Alvotech’s portfolio of six biosi

Kamada Enters into Partnership with Alvotech for Commercialization of Six Biosimilar Products in Israel, Expects Revenue of $20-$30M Within Several Years of Launch

12:00am, Monday, 02'nd Dec 2019

Did Hedge Funds Drop The Ball On Kamada Ltd (KMDA) ?

03:04pm, Saturday, 30'th Nov 2019

We are still in an overall bull market and many stocks that smart money investors were piling into surged through November 22nd. Among them, Facebook and Microsoft ranked among the top 3 picks and the

The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug

12:00am, Tuesday, 26'th Nov 2019

33 Stocks Moving In Monday's Mid-Day Session

12:00am, Monday, 25'th Nov 2019

The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate

12:00am, Friday, 22'nd Nov 2019

Kamada Reaffirms FY19 Sales Guidance Of $125M-$130M vs $128.91M Est.

12:00am, Wednesday, 13'th Nov 2019

Kamada (KMDA) to Report Q3 Results: Wall Street Expects Earnings Growth

12:00am, Monday, 04'th Nov 2019

Kamada and Kedrion Biopharma Highlights Publication Of Results From Registration Study Of KEDRAB In Human Vaccines & Immunotherapeutics Medical Journal

12:00am, Tuesday, 29'th Oct 2019

Kamada to Present Corporate Overview at the —…–9 Cantor Global Healthcare Conference

12:00am, Tuesday, 24'th Sep 2019

Kamada Announces Extension Of GLASSIA Supply Agreement With Takeda

12:00am, Tuesday, 03'rd Sep 2019

Kamada Ltd. (KMDA) CEO Amir London on Q2 2019 Results - Earnings Call Transcript

12:00am, Sunday, 11'th Aug 2019

Kamada Earlier Reported Talks With Takeda Related To Potential Extension Of Period For Transition Of GLASSIA Manufacturing To Takeda

12:00am, Thursday, 08'th Aug 2019

Kamada Q2 EPS $0.15 Beats $0.14 Estimate, Sales $35.3M Beat $34.37M Estimate

12:00am, Tuesday, 06'th Aug 2019

Kamada Stock News

Kamada Wins a 12 Year Supply Contract Which is Expected to Add $8-$10M of Annual Revenue

Kamada Enters into Partnership with Alvotech for Commercialization of Six Biosimilar Products in Israel

Kamada Enters into Partnership with Alvotech for Commercialization of Six Biosimilar Products in Israel, Expects Revenue of $20-$30M Within Several Years of Launch

Did Hedge Funds Drop The Ball On Kamada Ltd (KMDA) ?

The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug

33 Stocks Moving In Monday's Mid-Day Session

The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate

Kamada Reaffirms FY19 Sales Guidance Of $125M-$130M vs $128.91M Est.

Kamada (KMDA) to Report Q3 Results: Wall Street Expects Earnings Growth

Kamada and Kedrion Biopharma Highlights Publication Of Results From Registration Study Of KEDRAB In Human Vaccines & Immunotherapeutics Medical Journal

Kamada to Present Corporate Overview at the —…–9 Cantor Global Healthcare Conference

Kamada Announces Extension Of GLASSIA Supply Agreement With Takeda

Kamada Ltd. (KMDA) CEO Amir London on Q2 2019 Results - Earnings Call Transcript

Kamada Earlier Reported Talks With Takeda Related To Potential Extension Of Period For Transition Of GLASSIA Manufacturing To Takeda

Kamada Q2 EPS $0.15 Beats $0.14 Estimate, Sales $35.3M Beat $34.37M Estimate

Top Fintech Company